Clinical Profile and Results in Cancers Treated with Nivolumab: A Single Centre Study CancerImmunotherapyNivolumabIntroduction: Immunotherapy is also called as biologic therapy or biothera- py. Immunotherapy is quickly becoming an important component in the multipronged approaches being developed to treat ...
02 Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy 白介素-6是一种肝细胞癌联合免疫治疗患者循环预后的生物标志物 Yuta Myojin et al. https://www.mdpi....
LSD1 is highly expressed in SWI/SNF-mutant SCCOHT tumors and the inhibition of LSD1 activity exhibits remarkable anti-tumor efficacy when combined with immune checkpoint blockade70. These findings suggest the potential of LSD1 as a target for the combinational immunotherapy of SWI/SNF-mutated ...
were associated with better PFS.Conclusions:Our study provides a comprehensive overview of irAEs in advanced genitourinary cancers treated with immunotherapy. Ou... Y Zhang,J Chen,G Sun,... - 《Journal of Clinical Oncology》 被引量: 0发表: 2024年 Immunotherapy in the Treatment of Localized Gen...
Immunotherapy and chemotherapy of gynecologic cancers 来自 Semantic Scholar 喜欢 0 阅读量: 23 作者: RA Pattillo 摘要: Recurrent cervical, ovarian, and breast cancers have been treated with immunochemotherapy. Optimum chemotherapeutic agents have been determined by direct and indirect methods of ...
But only eight out of the 121 participants included in the study were treated with immunotherapy, prompting the study authors to stress that the sample was too small to make any conclusions based on this finding. The results do underscore the importance of receiving cancer screenings and treatment...
5a. e, Representative sections of hematoxylin and eosin-stained skin and liver from the 5 mice treated with anti-TRBC1-SG3249 ADC as in Fig. 5a. Untreated mice used as control (NSG mice, no ADC). Number of biological replicates, n = 5. f, Bioluminescence imaging of H9-injected ...
The past few decades have witnessed the rise of immunotherapy for Gastrointestinal (GI) tract cancers. The role of immune checkpoint inhibitors (ICIs), particularly programmed death protein 1 (PD-1) and PD ligand-1 antibodies, has become increasingly piv
Actuarial survival curves for a period of six years show significant (p less than 0.01) prolongation of survival of the small autografted group (63% at six years) compared to that (30% at six years) of 139 ungrafted stage 2 mammary cancer patients treated by mastectomy and postoperative ...
Our aim was to examine the relationship between TMB and outcome in diverse cancers treated with various immunotherapies. We reviewed data on 1,638 patients who had undergone comprehensive genomic profiling and had TMB assessment. Immunotherapy-treated patients (N = 151) were analyzed for response ...